Correlation between Adalimumab concentration, anti-drug antibody and clinical efficacy in rheumatoid arthritis and ankylosing spondylitis.

Wang X, Wu T, Xia X, Xing Q, Shi J, Xu S

DOI: 10.1186/s42358-026-00560-0
Published: 2026 Jun 22
Container: Advances in rheumatology (London, England)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s42358-026-00560-0,
  title = {Correlation between Adalimumab concentration, anti-drug antibody and clinical efficacy in rheumatoid arthritis and ankylosing spondylitis.},
  author = {Wang X and Wu T and Xia X and Xing Q and Shi J and Xu S},
  year = {2026},
  journal = {Advances in rheumatology (London, England)},
  doi = {10.1186/s42358-026-00560-0},
  url = {https://doi.org/10.1186/s42358-026-00560-0}
}

RIS

TY  - JOUR
TI  - Correlation between Adalimumab concentration, anti-drug antibody and clinical efficacy in rheumatoid arthritis and ankylosing spondylitis.
AU  - Wang X
AU  - Wu T
AU  - Xia X
AU  - Xing Q
AU  - Shi J
AU  - Xu S
PY  - 2026
JO  - Advances in rheumatology (London, England)
DO  - 10.1186/s42358-026-00560-0
UR  - https://doi.org/10.1186/s42358-026-00560-0
ER  -

APA

X, W., T, W., X, X., Q, X., J, S., & S, X. (2026). Correlation between Adalimumab concentration, anti-drug antibody and clinical efficacy in rheumatoid arthritis and ankylosing spondylitis.. Advances in rheumatology (London, England). https://doi.org/10.1186/s42358-026-00560-0

Source records

pubmed · retrieved 2026-09-26T12:07:29.187Z